2023

1. Differences in weight loss and safety between the glucagon-like peptide-1 receptor agonists: A non-randomized multicenter study from the titration phase

   Primary Care Diabetes, Vol. 17, Núm. 4, pp. 366-372

2. Effect of dapagliflozin on COVID-19 infection and risk of hospitalization

   The Journal of antimicrobial chemotherapy, Vol. 78, Núm. 9, pp. 2335-2342

3. Patients With High Cardiovascular Risk as Candidates to Bempedoic Acid, After Treatment With Statins, Ezetimibe and PCSK9 Inhibitors: An Estimation and Cost-Effectiveness Analysis

   Journal of cardiovascular pharmacology, Vol. 81, Núm. 1, pp. 70-75